Pharma BD Deal Intelligence

AbbVie Inc. / Shire plc

2014 · Acquisition/Merger · $54.0B · Terminated

Announcement Sentiment

Negative

Outcome Score

Underwhelmed — fell short of the thesis.

AbbVie agreed to acquire Shire in a $54 billion deal that would have moved AbbVie's tax domicile to Ireland. AbbVie terminated the deal in October 2014 after the US Treasury tightened tax inversion rules, paying Shire a $1.635 billion breakup fee.

Key facts

Announced Jul 18, 2014
Deal value $54.0B
Deal type Acquisition/Merger
Therapeutic area Immunology, Rare Disease
Key assets Shire rare disease portfolio

See the full interactive analysis, sources & comparables →

← Browse all deals · How we score deals